Skip to main content
. 2022 Jun 11;15:17562848221100946. doi: 10.1177/17562848221100946

Figure 2.

Figure 2.

Distribution of IBS diagnosis subtypes in patients using linaclotide, by country.

IBS, irritable bowel syndrome; IBS-C, IBS predominantly with constipation; IBS-D, IBS predominantly with diarrhea; IBS-M, IBS with mixed bowel habits; IBS-U, IBS unsubtyped. UK, United Kingdom.